国产精品视频观看,又大又粗有色,琪琪吊操人妻日韩精品,欧美 国产 日韩成人

服務熱線

15021010459
技術文章
當前位置:主頁 > 技術文章 > Ariad抗癌藥Iclusig重返市場

Ariad抗癌藥Iclusig重返市場

更新時間:2014-01-20 點擊次數:1709

    去年Ariad Pharmaceuticals公司業(yè)績由于主打抗癌藥物Iclusig被緊急下架而遭受重創(chuàng)。公司一度陷入困境并將其在美國的員工裁員160人,約占美 國分部總員工數的40%,以節(jié)省開支。不過現(xiàn)在Ariad Pharmaceuticals公司迎來一絲曙光。公司已經著手將Iclusig重新推向市場。此次Ariad將把Iclusig的適用癥范圍縮小,并在 藥物包裝上標明可能出現(xiàn)的副作用如心臟病、血液凝塊等。不過由于Iclusig適用范圍變小,公司的收入可能也會大受影響。為解決這一問題公司計劃申請重 啟此前被FDA下令暫停的關于Iclusig治療慢性白血病的研究計劃以達到亡羊補牢的作用。

    不過Ariad Pharmaceuticals公司的這一系列舉措能否獲得預期效果還需要等待公司2014年*季度財報公布后才能知曉。

詳細英文報道:

    Last year, Ariad Pharmaceuticals ($ARIA) watched more than $2.5 billion melt off its market cap when the cancer-fighting Iclusig began a downward spiral that would eventually remove it from the market. But now begins the rebuilding project, as the Cambridge, MA, drugmaker has relaunched its sole product with a lot of ground to make up.

    The drug is now indicated for a smaller group of leukemia patients than before, and it carries a serious boxed warning about the risk of clotting and heart failure that got it pulled from shelves in the fall. But it is for sale, and that puts Ariad in a better place than many predicted at its nadir.

    "We are back on track," CEO Harvey Berger told Bloomberg last month. "We'll enter 2014 largely where we were as we started off the fall in September."

    Of course, that's not entirely the case. Losing more than half of its value forced Ariad to considerably thin its ranks, laying off 40% of its U.S. workforce--or 160 employees--in an effort to save $26 million. Now the company plans to gradually ramp up stateside sales with the help of specialty pharmacy Biologics, Inc., first looking to transition the case-by-case patients who were still using the drug during its marketing hiatus.

    And the company has a long way to go on the R&D side. When the storm over Iclusig began, Ariad was in the process of testing the drug in a broader population, but an FDA-imposed clinical hold led the company to discontinue a Phase III study on patients with newly diagnosed chronic myeloid leukemia and put the brakes on a fleet of Phase II studies designed to expand the drug's market. Berger has said that Ariad is yet to decide just how to move forward with its paused programs.

    Still, the biotech is undeniably sitting prettier than it was just two months ago, and its next big test will come when Q1 sales figures roll in.——(華雅干細胞整理報道)

2025 版權所有 © 重慶市華雅干細胞技術有限公司  備案號:渝ICP備14000349號-4 sitemap.xml 管理登陸 技術支持:化工儀器網

地址:重慶市江北區(qū)金渝大道153號8棟20-14 傳真:023-63419626 郵件:sales@ys-bio.com

重慶市華雅干細胞技術有限公司主要經營干細胞研究 干細胞治療產品 生物試劑 實驗耗材 藥物研發(fā)等產品。

關注我們

服務熱線

400-021-2200

掃一掃,關注我們

欧美精品在线视频| 国产XXXX99真实实拍| 后入无码在线观看| 变态另类久久| 精品国产综合区久久久久久小网站| 国产剧精品一区AV| 午夜麻豆国产精品无码导航| 激情小五月欧美| 欧美日韩专区国产精品| 无码国产精品| 免费97久久久人妻一区精品 | 国产精品第一区二| 久久国产亚洲欧美| 大香蕉尹| 久久亚洲国产女同av| 久草中文视频| 亚洲欧美在线淋| A国产区| 亚洲国产精品成人久久青草| 亚洲AV无码不卡DVD| 日韩人妻无码肉v视频| 妺妺窝人体色www_聚色窝| 美腿丝袜香蕉网| 无遮挡在线观看| 亚洲国产日韩在线| 精品人妻无码专区| 国产欧美日韩一级黄片儿| 无码免费看片一区二区三区| 亚洲激情人妻乱| 日韩 人视频| 无打码日本黄色网站| 牛牛影视99| 正在播放无码破解流出| 国产一区无码在线播放| 亚洲色图一区不打码视频| 亚洲av高清内射大全| 色综合久久中文字幕无码| 爆乳少妇高清无码区| 曰韩愉情| avv天堂网| 一级a一级a爱片免费免免高潮 |